VALIDOGEN GmbH

VALIDOGEN, founded in 2008 as VTU Technology GmbH and renamed VALIDOGEN GmbH in October 2018, is a leading contract research and development organization (CRO) specializing in recombinant protein expression using its exclusive UNLOCK PICHIA® protein expression technology. With its UNLOCK PICHIA® platform, VALIDOGEN applies a broad and unique portfolio of technologies for successful and economically viable production of recombinant proteins in the yeast Pichia pastoris (also known as as Komagataella phaffii), serving many industries including biopharma, food & feed, industrial biotechnology, and diagnostics. VALIDOGEN provides advanced Pichia strain generation as well as fermentation and protein purification process development for the manufacture of biopharmaceuticals, enzymes, and other recombinant proteins. Based on our strong Pichia expertise, customers from different industries have successfully scaled up commercial production processes with highly effective Pichia strains for the production of recombinant proteins for pharma and non-pharma applications. Headquartered in Raaba-Grambach, near Graz, Austria, VALIDOGEN is a private company and subsidiary of KonValue Holding GmbH. WORKING WITH VALIDOGEN 15+ YEARS EXPERIENCE Pichia strain generation & optimization, plus process development for enhanced protein production UNLOCK PICHIA® TOOLBOX Broad and versatile protein expression technology platform for Pichia pastoris CUSTOMER-ORIENTED SERVICES Customized project plans in small, modular packages suitable for every industry _____________________________________________________________________________ For more information on VALIDOGEN and how we UNLOCK PICHIA® for maximization of protein production visit www.validogen.com